(Q47572384)

English

CD205 antigen targeting combined with dendritic cell recruitment factors and antigen-linked CD40L activation primes and expands significant antigen-specific antibody and CD4(+) T cell responses following DNA vaccination of outbred animals.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

CD205 antigen targeting combined with dendritic cell recruitment factors and antigen-linked CD40L activation primes and expands significant antigen-specific antibody and CD4(+) T cell responses following DNA vaccination of outbred animals (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Christopher J. Davies

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Leo M Njongmeta

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Jocelyn Bray

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

William C Davis

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Chris J Howard

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Guy H Palmer

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Wendy C Brown

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Waithaka Mwangi

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

0 references

publication date

10 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1624-1635

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Prospects for control of emerging infectious diseases with plasmid DNA vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Optimization and delivery of plasmid DNA for vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Direct gene transfer into mouse muscle in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Induction in humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Targeting with bovine CD154 enhances humoral immune responses induced by a DNA vaccine in sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

DNA-encoded fetal liver tyrosine kinase 3 ligand and granulocyte macrophage-colony-stimulating factor increase dendritic cell recruitment to the inoculation site and enhance antigen-specific CD4+ T cell responses induced by DNA vaccination of outbre

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

DNA vaccine construct incorporating intercellular trafficking and intracellular targeting motifs effectively primes and induces memory B- and T-cell responses in outbred animals.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Enhancement of immunogenicity of a therapeutic cervical cancer DNA-based vaccine by co-application of sequence-optimized genetic adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Enhancing DNA immunization by targeting ASFV antigens to SLA-II bearing cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Induction of protection against porcine cysticercosis in growing pigs by DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Vaccination of turkeys against Chlamydophila psittaci through optimised DNA formulation and administration.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

CD4+ T-cell induction and effector functions: a comparison of immunity against soluble antigens and viral infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Plasmid vaccine expressing granulocyte-macrophage colony-stimulating factor attracts infiltrates including immature dendritic cells into injected muscles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Effect of different promoters on immune responses elicited by HIV-1 gag/env multigenic DNA vaccine in Macaca mulatta and Macaca nemestrina

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

DNA-based immunization by in vivo transfection of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

The dendritic cell system and its role in immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

DNA vaccination: transfection and activation of dendritic cells as key events for immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

A monoclonal antibody specific for mouse dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Recruitment of dendritic cells and enhanced antigen-specific immune reactivity in cancer patients treated with hr-GM-CSF (Molgramostim) and hr-IL-2. results from a phase Ib clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Granulocyte-macrophage colony-stimulating factor priming plus papillomavirus E6 DNA vaccination: effects on papilloma formation and regression in the cottontail rabbit papillomavirus--rabbit model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Immunomodulatory effect of swine CCL20 chemokine in DNA vaccination against CSFV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Effect of plasmid DNA encoding the porcine granulocyte-macrophage colony-stimulating factor on antigen-presenting cells in pigs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

A versatile bifunctional dendritic cell targeting vaccine vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Single chain antibody fragments for the selective targeting of antigens to dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Inhibition of melanoma growth by targeting of antigen to dendritic cells via an anti-DEC-205 single-chain fragment variable molecule

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti–human DEC205 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Modulation of cellular responses by plasmid CD40L: CD40L plasmid vectors enhance antigen-specific helper T cell type 1 CD4+ T cell-mediated protective immunity against herpes simplex virus type 2 in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

CD40 ligand (CD154) enhances the Th1 and antibody responses to respiratory syncytial virus in the BALB/c mouse

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Molecular basis for surface antigen size polymorphisms and conservation of a neutralization-sensitive epitope in Anaplasma marginale

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Molecular basis for vaccine development against the ehrlichial pathogen Anaplasma marginale

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Molecular basis for vaccine development against anaplasmosis and babesiosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

CD4(+) T lymphocytes from calves immunized with Anaplasma marginale major surface protein 1 (MSP1), a heteromeric complex of MSP1a and MSP1b, preferentially recognize the MSP1a carboxyl terminus that is conserved among strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Characterization of a neutralization-sensitive epitope on the Am 105 surface protein of Anaplasma marginale

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Major histocompatibility complex class II DR-restricted memory CD4(+) T lymphocytes recognize conserved immunodominant epitopes of Anaplasma marginale major surface protein 1a.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

DEC-205 expression on migrating dendritic cells in afferent lymph

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Current applications of COS cell based transient expression systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Recombinant soluble trimeric CD40 ligand is biologically active

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Cloning of two members of the TNF-superfamily in cattle: CD40 ligand and tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Characterization of a phenotypically unique population of CD13+ dendritic cells resident in the spleen.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Identification of fetal liver tyrosine kinase 3 (flt3) ligand domain required for receptor binding and function using naturally occurring ligand isoforms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Enhancement of antigen acquisition by dendritic cells and MHC class II-restricted epitope presentation to CD4+ T cells using VP22 DNA vaccine vectors that promote intercellular spreading following initial transfection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

In situ recruitment of antigen-presenting cells by intratumoral GM-CSF gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Absorbable microparticulate cation exchanger for immunotherapeutic delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Quantitation of Anaplasma marginale major surface protein (MSP)1a and MSP2 epitope-specific CD4+ T lymphocytes using bovine DRB3*1101 and DRB3*1201 tetramers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Newcastle disease virus expressing a dendritic cell-targeted HIV gag protein induces a potent gag-specific immune response in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Improved immunogenicity of a self tumor antigen by covalent linkage to CD40 ligand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Linkage of CD40L to a self-tumor antigen enhances the antitumor immune responses of dendritic cell-based treatment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Immunotargeting with CD154 (CD40 ligand) enhances DNA vaccine responses in ducks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Immunogenicity and protective efficacy of a DNA vaccine encoding a chimeric protein of avian influenza hemagglutinin subtype H5 fused to CD154 (CD40L) in Pekin ducks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Synergistic antibody induction by antigen-CD40 ligand fusion protein as improved immunogen.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Rapid deletion of antigen-specific CD4+ T cells following infection represents a strategy of immune evasion and persistence for Anaplasma marginale

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Characterization of lymphocyte subpopulations and major histocompatibility complex haplotypes of mastitis-resistant and susceptible cows.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Characterization of an immunoprotective protein complex of Anaplasma marginale by cloning and expression of the gene coding for polypeptide Am105L.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

based on heuristic

inferred from DOI database lookup

CD4(+) T-lymphocyte and immunoglobulin G2 responses in calves immunized with Anaplasma marginale outer membranes and protected against homologous challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2011.12.110

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47572384&oldid=1790314521"